Beijing Kinghawk Pharmaceutical Co., Ltd (Kinghawk Pharmaceutical for short) is a high-tech enterprise specializing in bio-technology and product development. With registered capital of 42 million Yuan, founded in 1993 and located in the unique state-level development zones of Beijing, Beijing Economic and Technological Development Area, known as the Beijing Medicine canyon, Kinghawk Pharmaceutical covers 6000 m2, the company is certified by the “Good Manufacturing Practice”(GMP) and ISO13485:2003, ISO9001:2008, the company successful listing at ZhongGuanCun third board in Beijing(Stock Short Name: Kinghawk pharmaceutical, Stock Code: 430026) and joined into Beijing “G20” project .The CCAP Test Center has passed the evaluation of China National Accreditation Service for Conformity Assessment(CNAS)and received the ISO 17025 certification in 2012.
Since Kinghawk established, in line with the Spirit of forge ahead, realistic and innovative, Kinghawk has developed 150 in vitro diagnostic kits covering the Colloidal ,ELISA, Blood Grouping, PCR, CLIA, Clinical Chemistry, and Standard Reference. We own 6 production lines of colloidal , ELISA,PCR, blood grouping ,clinical chemistry and standard reference. Kinghawk has successfully established the domestic first-class operation platform of information, scientific, research, production, sales and training, in the same time, Kinghawk has established a good technical exchanges and cooperation between enterprises and research institutions from domestic and abroad.
Kinghawk Pharmaceuticalpursues the “pursuit of excellence,dedication to society” business purposes; adhere to the “integrity, rigorous,diligent,
innovation”corporate philosophy. Dedicate to the health of human beings and stop disease transmission.